Items where Author / Artist / Editor is "Farrelly, Angela"

Article

Kalachand, Roshni D., O'Riain, Ciaran, Toomey, Sinead, Carr, Aoife, Timms, Kirsten M., O'Toole, Sharon, Madden, Stephen, Bates, Mark, O'Leary, John J., Gleeson, Noreen, O'Donnell, Dearbhaile, Grogan, Liam, Breathnach, Oscar, Farrelly, Angela, Stordal, Britta K. ORCID: https://orcid.org/0000-0002-7892-951X and Hennessy, Bryan T. (2020) Prevalence of tumor BRCA1 and BRCA2 dysfunction in unselected patients with ovarian cancer. Obstetrics & Gynecology Science, 63 (5) . pp. 643-654. ISSN 2287-8572 [Article] (doi:10.5468/ogs.20033)

Stordal, Britta K. ORCID: https://orcid.org/0000-0002-7892-951X, Timms, Kirsten, Farrelly, Angela, Gallagher, Danielle, Busschots, Steven, Renaud, Mickaël, Thery, Julien, Williams, Deborah, Potter, Jennifer, Tran, Thanh, Korpanty, Greg, Cremona, Mattia, Carey, Mark, Li, Jie, Li, Yang, Aslan, Ozlem, O'Leary, John J., Mills, Gordon B. and Hennessy, Bryan T. (2013) BRCA1/2 mutation analysis in 41 ovarian cell lines reveals only one functionally deleterious BRCA1 mutation. Molecular Oncology, 7 (3) . pp. 567-79. ISSN 1878-0261 [Article] (doi:10.1016/j.molonc.2012.12.007)

Conference or Workshop Item

Kalachand, Roshni D, Cremona, Mattia, Farrelly, Angela, Eustace, Alex J., Stordal, Britta K. ORCID: https://orcid.org/0000-0002-7892-951X and Hennessy, Bryan T. (2018) PO-495 PI3K pathway upregulation mediates acquired resistance to platinum agents and polyadenoribose polymerase inhibitors (PARPi) in BRCA1-methylated ovarian cancer (OC). In: EACR25: The 25th Biennial Congress of the European Association for Cancer Research, 30 Jun - 3 Jul 2018, Amsterdam, Netherlands. . [Conference or Workshop Item]

Stordal, Britta K. ORCID: https://orcid.org/0000-0002-7892-951X, Timms, Kirsten M., Renuad, Mickael, Thery, Julien, Farrelly, Angela, Williams, Deborah, Potter, Jennifer, Tran, Thanh, Korpanty, Greg, Cremona, Mattia, Carey, Mark S., Li, Jane, Li, Yang, Aslan, Ozlem, O'Leary, John J., Mills, Gordon B. and Hennessy, Bryan T. (2012) BRCA1/2 mutation analysis in 43 ovarian cell lines reveals only one functionally deleterious BRCA1 mutation. Proceedings of the 103rd Annual Meeting of the American Association for Cancer Research; 2012 Mar 31-Apr 4; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2012;72(8 Suppl). In: 103rd Annual Meeting of the American Association for Cancer Research (AACR), 31 Mar - 04 Apr 2012, Chicago. . [Conference or Workshop Item] (doi:10.1158/1538-7445.AM2012-78)